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OBJECTIVE—The sites of insulin action in the central nervous
system that regulate glucose metabolism and energy expenditure
are incompletely characterized. We have shown that mice with
hypothalamic deﬁciency (L1) of insulin receptors (InsRs) fail to
regulate hepatic glucose production (HGP) in response to
insulin.
RESEARCH DESIGN AND METHODS—To distinguish neu-
rons that mediate insulin’s effects on HGP from those that
regulate energy homeostasis, we used targeted knock-ins to
express InsRs in agouti-related protein (AgRP) or proopiomela-
nocortin (POMC) neurons of L1 mice.
RESULTS—Restoration of insulin action in AgRP neurons nor-
malized insulin suppression of HGP. Surprisingly, POMC-speciﬁc
InsR knock-in increased energy expenditure and locomotor
activity, exacerbated insulin resistance and increased HGP,
associated with decreased expression of the ATP-sensitive K

channel (KATP channel) sulfonylurea receptor 1 subunit, and
decreased inhibitory synaptic contacts on POMC neurons.
CONCLUSIONS—The contrasting phenotypes of InsR knock-
ins in POMC and AgRP neurons suggest a branched-pathway
model of hypothalamic insulin signaling in which InsR signaling
in AgRP neurons decreases HGP, whereas InsR activation in
POMC neurons promotes HGP and activates the melanocortin-
ergic energy expenditure program. Diabetes 59:337–346, 2010
I
nsulin receptor (InsR) signaling in the central ner-
vous system (1,2) regulates energy balance (3).
Inactivation of InsR in neurons and glia (“NIRKO”
mice) predisposes to diet-induced obesity (4),
whereas intracerebroventricular insulin administration re-
sults in acute suppression of food intake (3,5,6) and
stimulation of energy expenditure (7). Furthermore, cen-
tral nervous system insulin signaling regulates glucose
metabolism. NIRKO mice show mild insulin resistance (4).
And hypothalamic insulin signaling via phosphatidylinosi-
tol 3-kinase (PI 3-kinase) and ATP-sensitive K
 channels
(KATP channels) (8) is required for insulin suppression of
hepatic glucose production (HGP) (9,10).
The functional neuroanatomy of InsR signaling has yet
to be mapped. Conditional ablation of InsR in agouti-
related protein (AgRP) neurons results in altered HGP,
whereas proopiomelanocortin (POMC) neuron-speciﬁc
knockout is conspicuous by its lack of phenotype (11). But
unlike leptin receptor signaling, where it has been possible
to dissect pathways regulating food intake from those
regulating energy expenditure (12) and reproduction (13),
the question of which neurons mediate speciﬁc actions of
insulin remains largely unsettled.
Using a genetic reconstitution approach, we have em-
barked on a systematic analysis of tissue interactions
required to maintain normal insulin sensitivity. Complete
ablation of InsR results in lethal neonatal diabetes (14)
that, surprisingly, can be rescued by restoring InsR expres-
sion in liver, pancreatic -cells, and several brain regions
(L1 mice) (15). L1 mice have a 90% reduction of InsR
levels in the hypothalamic arcuate nucleus (ARC) and
blunted insulin signaling in hypothalamic cell extracts,
associated with impaired regulation of HGP (10). Thus,
they can be considered a model of impaired insulin
signaling in key hypothalamic cell subpopulations, whose
neuropeptide products have profound effects on energy
homeostasis (3). To analyze the contribution of these
different neuronal cell types to insulin action, we used a
gain-of-function approach to reconstitute InsR expression
in either AgRP or POMC neurons of L1 mice and analyzed
their bioenergetic and metabolic phenotypes.
RESEARCH DESIGN AND METHODS
Mice. Insr
–/– (14), Ttr-INSR transgenic, ac/INSR knock-in (15), Foxo1
ﬂox/ﬂox
(16), Agrp-Cre (17), and Pomc-Cre (18) mice have been previously described.
Insr
/–::Ttr-INSR::ac/INSR mice were intercrossed with Agrp-Cre or Pomc-
Cre mice to generate Insr
–/–::Ttr-INSR::ac/INSR::Agrp-Cre (Agrp-KI) and
Insr
–/–::Ttr-INSR::ac/INSR::Pomc-Cre (Pomc-KI) mice. Wild-type littermates
were used as controls. Genotyping was performed as previously described
(15,17–19). Embryonic recombination of the ac/INSR locus was detected by
PCR from tail DNA of an 200-bp product using primers 5-GGTTTTCCTTT
GAAAAACACG-3 and 5-CTTAATCGCCTTGCAGCACAT-3. Foxo1
POMC
(Foxo1
ﬂox/ﬂox::Pomc-Cre) mice were obtained by mating Foxo1
ﬂox/ﬂox mice
with Pomc-Cre mice (18). All animal procedures have been approved by the
Columbia University Institutional Animal Care and Utilization Committee.
Metabolic analyses. Metabolites were measured as described (20). Free fatty
acids and triglycerides were measured with NEFA-HR test reagents (Wako
Chemicals, Richmond, VA) and serum triglyceride determination kit (Sigma,
St. Louis, MO). Insulin and leptin were measured by enzyme-linked immu-
nosorbent assay; adiponectin, resistin, tissue plasminogen activator inhibitor
1, interleukin-6 (IL-6), and tumor necrosis factor- by Luminex (Linco
Research, St. Charles, MO); IGF-1 (Alpco Diagnostics, Salem, NH), corticoste-
rone (MP Biomedicals, Solon, OH), glucagon, and C-peptide by radioimmu-
noassay. Body composition was determined using Bruker Minispec NMR
(Bruker Optics, The Woodlands, TX).
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diabetes.diabetesjournals.org DIABETES, VOL. 59, FEBRUARY 2010 337Body weight and food intake. Body weight was measured weekly. Food
intake was measured biweekly in 6- to 12-week-old mice using manual feeding
hoppers. For refeeding studies, after acclimation mice were fasted overnight.
Feeding hoppers were placed in the cages 2 h after the start of the light phase,
and food intake was measured 6 h after feeding hoppers were placed.
Glucagon and stress response. For glucagon measurement, fasting was
started 2 h after the onset of the light phase. After a 6-h fast, blood was drawn
from the tail vein. One week later, mice were again fasted for 6 h, followed by
an intraperitoneal insulin injection (0.75 units/kg). Blood glucose was mea-
sured immediately before insulin injection and at 30 and 60 min after the
injection. Mice used for analyses of the stress response were familiarized with
gentle handling for 6–8 weeks prior to the experiment. For determination of
basal plasma corticosterone, blood was drawn from the tail 1–2 h after the
start of the light phase.
Euglycemic-hyperinsulinemic clamp studies. Four groups of 14- to 16-
week-old normoglycemic male mice were studied: wild type (n  8), L1 (n 
13), Agrp-KI (n  8), and Pomc-KI (n  7). We performed euglycemic-
hyperinsulinemic clamps in conscious, catheterized mice as described (10).
Indirect calorimetry. Indirect calorimetry was performed using a TSE
LabMaster system (TSE Systems). Individually housed mice were acclimated
to the respiratory chambers for 24–36 h prior to the experiment, and gas
exchanges, locomotor activity, and food intake were measured every 14 min
for 3–6 days.
RNA isolation and RT-PCR analyses. We extracted total RNA using RNeasy
Mini Kit and RNase-Free DNase Set (Qiagen, Valencia, CA). Quantitative PCRs
were performed in triplicate using a DNA Engine Opticon 2 System (Bio-Rad,
Hercules, CA) and DyNAmo HS SYBR green Q-PCR kit (New England Biolabs,
Ipswich, MA). Primer sequences are available upon request. Relative mRNA
levels were normalized to 36B4 (for liver and hypothalamus) or Rps3 (for
white adipose tissue).
Western blotting. We prepared detergent extract from liver and muscle as
described (20) and probed the membranes with antibodies against phos-
pho-Akt (Ser473), total Akt, phospho-Stat3 (Tyr705) (Cell Signaling, Danvers,
MA), total Stat3, InsR(C-19), and -actin (Santa Cruz Biotechnology, Santa Cruz,
CA).
Green ﬂuorescent protein immunohistochemistry. We perfused mice
transcardially with PBS followed by formalin, ﬁxed and dissected brains,
equilibrated them in 30% sucrose, and froze them in OCT (Sakura, Torrance,
CA). We used 30-	m–thick coronal sections for green ﬂuorescent protein
immunostaining on free-ﬂoating sections with a polyclonal rabbit antiserum
(Molecular Probes/Invitrogen, Carlsbad, CA).
PIP3 measurements. Phosphatidylinositol 3,4,5-trisphosphate (PIP3) immu-
nostaining was performed as previously described (21) using a ﬂuorescein
isothiocyanate–conjugated antibody (catalog no. Z-G345; Echelon Bio-
sciences, Salt Lake City, UT), a horseradish peroxidase–conjugated ﬂuores-
cein isothiocyanate antibody, and TSA ﬂuorescein tyramide reagent pack
(PerkinElmer, Waltham, MA). For quantitative analysis of PIP3 levels, three
coronal sections of each mouse at approximately Bregma 
1.3 mm, 
1.4 mm,
and 
1.5 mm were examined. A total of 700–850 cells per mouse were
examined as previously described (6). Results were quantiﬁed and expressed
as percentage of ARC cells showing moderate to high PIP3 levels.
Synaptology. The hypothalamus was dissected from 15- to 17-week-old male
mice, and cut in 50-	m vibratome sections that were processed and analyzed
as described (22). Owing to signiﬁcant nonhomogeneity of variance among
groups, data were analyzed by one-way nonparametric ANOVA (Kruskal-
Wallis), and Mann-Whitney U test was used to determine signiﬁcance (P 
0.05).
Statistical methods. We analyzed data with one-way ANOVA followed by
post hoc Bonferroni test using SPSS software.
RESULTS
Generation of Agrp-KI and Pomc-KI mice. To investi-
gate the contribution of InsR signaling in AgRP and/or
POMC neurons to insulin sensitivity and energy homeosta-
sis, we reactivated InsR expression speciﬁcally in either of
these neuron populations in L1 mice using a conditional
locus knock-in approach (supplementary Fig. 1A and B,
available in an online appendix at http://diabetes.
diabetesjournals.org/cgi/content/full/db09-1303/DC1) (15).
L1 mice in which Cre-mediated recombination resulted in
InsR expression in AgRP or POMC neurons are denoted as
Agrp knock-in (Agrp-KI) or Pomc knock-in (Pomc-KI),
respectively. Cre-mediated recombination was assessed
by intercrossing Cre transgenic lines with Rosa26-Gfp
mice and revealed the expected expression patterns in
ARC AgRP and POMC neurons (supplementary Fig. 1C
and D), without affecting InsR levels in peripheral tissues
(supplementary Fig. 1E and F).
To determine the effects of AgRP neuron– or POMC
neuron–speciﬁc InsR reconstitution, we measured insu-
lin’s ability to activate the PI 3-kinase pathway in wild-
type, L1, Agrp-KI, and Pomc-KI mice (21). In wild-type
mice, we detected PIP3 immunoreactivity in 15.7% of ARC
cells in the fasted state and in 22.5% of cells after insulin
stimulation (Fig. 1A and B)( P  0.05). Insulin failed to
stimulate PIP3 formation in ARC of L1 mice (19.6 fasted
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FIG. 1. PIP3 formation in ARC cells of wild-type, L1, Pomc-KI, and
Agrp-KI mice. A: Immunohistochemistry of ARC sections of wild-type,
L1, Pomc-KI, and Agrp-KI mice was performed in overnight-fasted
animals, which were intravenously injected with either saline (left
panels) or insulin (right panels) and killed 10 min after stimulation.
Blue, DNA; green, PIP3. The amount of PIP3 was classiﬁed as high
(arrows), moderate (arrowheads), or low as previously described (6).
B: Quantiﬁcation of ARC cells displaying moderate to high PIP3 levels
in the basal state (sal) and after insulin stimulation (ins). n  4–6
mice per group; 800–1,000 ARC cells per mouse were examined. Data
are means  SEM. *P < 0.05, **P < 0.01 saline versus insulin. (A
high-quality digital representation of this ﬁgure is available in the
online issue.)
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Pomc-KI mice (18.8 vs. 25.8%) and Agrp-KI (17.9 vs. 24.0%)
mice, consistent with restoration of insulin/PI 3-kinase
signaling in deﬁned subpopulations of ARC neurons.
Opposite effects on insulin sensitivity in Agrp-KI and
Pomc-KI mice. The expectation of the current study was
that, by reconstituting InsR function in AgRP neurons or
POMC neurons of L1 mice, insulin suppression of HGP
would be restored. Consistent with previous reports
(10,15), L1 mice showed hyperinsulinemia in the fasted
and fed states, and 13% became diabetic by 12 weeks of
age (Fig. 2A and B). Agrp-KI mice showed signiﬁcant
reductions in both fasted and fed insulin levels compared
with L1, and only 9% were diabetic at 12 weeks. Pomc-KI
mice showed insulin levels similar to L1 mice, but the
frequency of diabetes nearly doubled to 23%. To circum-
vent potential secondary effects of chronic hyperglyce-
mia on metabolism and energy homeostasis, we
excluded diabetic L1, Agrp-KI, and Pomc-KI animals
from further analyses. In intraperitoneal glucose toler-
ance tests, nondiabetic L1, Agrp-KI, and Pomc-KI mice
displayed modest glucose intolerance compared with
wild type (supplementary Fig. 2A), whereas insulin
tolerance tests did not reveal differences among the four
genotypes (supplementary Fig. 2B).
To accurately probe hepatic insulin sensitivity, we per-
formed euglycemic hyperinsulinemic clamps in nondia-
betic mice (Fig. 2C–F). Consistent with the results of
glucose tolerance tests, rates of whole-body glucose dis-
appearance in L1, Agrp-KI, and Pomc-KI mice were 10, 24,
and 28% lower than wild type (Fig. 2E), respectively,
indicating modest reductions in tissue glucose uptake. As
previously described (10), the glucose infusion rate (GIR)
required to maintain euglycemia was reduced by 36% and
HGP was increased fourfold in L1 mice compared with
wild type (Fig. 2D and F), consistent with hepatic insulin
resistance. HGP was restored to normal in Agrp-KI mice,
indicating that InsR in AgRP neurons is sufﬁcient for
insulin inhibition of HGP. In contrast, Pomc-KI mice
exhibited a further 64% reduction in GIR and a 78%
increase in HGP compared with L1, indicating a marked
increase in hepatic insulin resistance.
This unexpected result prompted us to investigate the
mechanism whereby InsR reconstitution in POMC neurons
leads to a deterioration of hepatic insulin sensitivity. Changes
in hepatic insulin signaling and counterregulatory responses
failed to explain the phenotype (supplementary Figs. 3–6).
We then explored two mutually nonexclusive hypotheses: 1)
altered regulation of genes involved in hypothalamic glucose
sensing; and 2) impaired neuropeptide regulation with atten-
dant abnormalities of energy balance.
Reduced expression of hypothalamic KATP channels
in Pomc-KI– and POMC-speciﬁc forkhead box class O
knockout mice. Hypothalamic KATP channels link mem-
brane excitability with cellular metabolism, and are regu-
lated by glucose (23,24), insulin (25,26), and leptin (27).
Cells in the mediobasal hypothalamus, including 75% of
POMC neurons, express the KATP channel sulfonylurea
receptor 1 (SUR1) and Kir6.2 subunits (encoded by Abcc8
and Kcnj11, respectively) (8,21,28). Activation of hypotha-
lamic KATP channels lowers HGP, whereas SUR1 deﬁ-
ciency curtails insulin suppression of HGP (8). To
determine whether abnormalities of KATP channel expres-
sion contribute to the increased HGP in Pomc-KI mice, we
examined hypothalamic Abcc8 and Kcnj11 levels in fasted
and in clamped mice. We detected a signiﬁcant 43%
reduction of Abcc8 expression in clamped Pomc-KI mice
compared with L1 and Agrp-KI mice (Fig. 3A), but no
signiﬁcant difference in Kcnj11 among the four genotypes
(Fig. 3B). The decrease of Abcc8 is consistent with a
reduction in insulin’s ability to decrease neuronal ﬁring,
which in turn may contribute to increased HGP. (Fasted
levels were also lower in Pomc-KI versus wild-type mice,
but the difference failed to reach statistical signiﬁcance.)
To further demonstrate that the observed reduction in
Abcc8 expression was linked to InsR signaling in POMC
neurons, we measured hypothalamic Abcc8 mRNA in mice
lacking the insulin-regulated transcription factor forkhead
box class O (FoxO1) in POMC neurons (Foxo1
POMC). The
prediction was that Foxo1
POMC mice should phenocopy
the reduced Abcc8 levels of Pomc-KI mice. Indeed, we
found a 53% decrease of Abcc8 in Foxo1
POMC mice (Fig.
3C), consistent with our hypothesis that InsR signaling
decreases Abcc8 expression in POMC neurons.
Synaptic contacts in Pomc-KI mice. Owing to the
complex genotype of Pomc-KI mice, we could not obtain
primary neuronal cultures from newborns to perform
electrophysiology. We thus performed a histomorphomet-
ric electron microscopy study of synaptic contacts, com-
paring wild-type, L1, and Pomc-KI mice. We found a
signiﬁcant decrease in the total number of synapses on
POMC neurons of L1 and Pomc-KI mice that was entirely
accounted for by decreased symmetric (putative inhibi-
tory) contacts, whereas asymmetric (putative stimulatory)
contacts were unchanged, resulting in increased ratios of
asymmetric/symmetric contacts (Table 1). Pomc-KI
mice had the lowest number of inhibitory contacts. This
is consistent with the fact that, as insulin inhibits POMC
neurons’ electrical activity (21), these neurons are likely
to recruit fewer inhibitory contacts from other cells. It
stands to reason that the lack of inhibitory connections
renders these neurons more excitable, leading to in-
creased HGP (29).
Hypermetabolic state in Pomc-KI mice. We next ex-
plored the contribution of altered energy balance and
hypothalamic neuropeptide expression to the impairment
of hepatic insulin sensitivity in Pomc-KI mice. As wean-
lings, L1, Agrp-KI, and Pomc-KI showed a 30% reduction of
body weight compared with wild-type mice, and exhibited
limited catch-up growth thereafter, attaining 90% of
normal weight at 16 weeks of age (Fig. 4A). This was
associated with a 25% decrease in plasma IGF-1 levels, and
resulted in an 11% decrease of BMIs (supplementary Table
1). Most importantly, for the purpose of the ensuing
studies, body composition of the four groups of mice was
similar (supplementary Table 1).
In view of the melanocortinergic (MCR) effects of
insulin in the hypothalamus (30), we predicted that energy
expenditure in L1 mice would reﬂect decreased MCR
signaling, and that AgRP and POMC knock-ins would
partially restore MCR effects. As reported previously, L1
mice had similar food intake to wild type (10) (Fig. 4B),
and exhibited Normal oxygen consumption (VO2) and
respiratory quotient (Fig. 4C–F). They also showed a
marked decrease in locomotor activity during the dark
phase of the light cycle (Fig. 4G and H). These data
indicate that some MCR actions are preserved in L1 mice
(food intake, VO2), whereas others are impaired (locomo-
tor activity and suppression of HGP) (31,32). InsR recon-
stitution in AgRP neurons failed to normalize locomotor
activity (Fig. 4G and H), but restored insulin suppression
of HGP (Fig. 2). There was a modest increase in VO2 during
H.V. LIN AND ASSOCIATES
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4B–F). Reconstitution of InsR in POMC neurons com-
pletely reversed the decrease in locomotor activity in L1
mice (Fig. 4G–H) and increased VO2 (Fig. 4C and D).
AgRP and POMC neurons project to the lateral hypo-
thalamus, the site of melanin-concentrating hormone
(Mch)– or hypocretin (Hcrt)–expressing neurons (33,34)
that have been implicated in the regulation of locomotor
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FIG. 2. Opposite effects on glucose homeostasis in Agrp-KI and Pomc-KI mice. A and B: Blood glucose levels (left panels) and plasma insulin levels
(right panels) in overnight-fasted (A) and ad libitum–fed (B) 12- to 14-week-old wild-type, L1, Agrp-KI, and Pomc-KI males (n  11–80). C:
Plasma insulin levels in 14- to 16-week-old, 3-h–fasted wild-type, L1, Agrp-KI, and Pomc-KI male mice before the hyperinsulinemic-euglycemic
clamp protocol (0 min) and during the steady state (mean of 60 and 90 min) of the clamps. D–F: GIRs (D), rates of whole-body glucose
disappearance (Rd) (E), and HGP during the steady state of the clamp studies (F)( n  8 for wild type, n  12 for L1, n  8 for Agrp-KI, and n 
7 for Pomc-KI). All values are means  SEM. *P < 0.05 versus wild type, **P < 0.01 versus wild type, ***P < 0.001 versus wild type, ****P < 0.0001
versus wild type, #P < 0.05, ##P < 0.01, ###P < 0.001.
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in all genotypes (supplementary Fig. 7). Under hyperinsu-
linemic clamp conditions, expression of Mch and Hcrt
tended to be elevated in L1, Agrp-KI, and Pomc-KI com-
pared with wild type, but the differences were not statis-
tically signiﬁcant.
The hypermetabolic state of Pomc-KI mice, in the
presence of normal body weight/composition, led us to
investigate their food intake. Pomc-KI mice showed
modest increases in ad libitum feeding (Fig. 4B) and a
36% increase in rebound food intake after fasting (Fig.
4I). This was associated with a 34–87% reduction in
plasma leptin levels under ad libitum–fed, overnight-
fasted, and 6-h–refed conditions compared with L1 mice
(Fig. 4J) and a parallel reduction in leptin mRNA
expression in adipose tissue (Fig. 4K). The dissociation
of leptin’s ability to modulate energy expenditure from
regulation of food intake in Pomc-KI mice provides
indirect evidence that MCR target neurons regulating
energy expenditure are distinct from those regulating
food intake (12).
We determined the ability of clamp-induced hyperinsu-
linemia to affect Agrp and Pomc expression by comparing
mRNA levels of the respective genes in fasted and in
clamped mice. Insulin infusion raised Pomc levels in
wild-type mice (Fig. 5A); the effect was blunted in L1 and
Agrp-KI, and normalized in Pomc-KI mice, consistent with
cell-autonomous restoration of InsR-dependent Pomc ac-
tivation. In contrast, Agrp levels were unaffected by clamp
hyperinsulinemia in wild-type mice, probably reﬂecting
different time course and dose sensitivity of insulin regu-
lation of this gene. Nonetheless, in L1 mice we observed a
trend toward insulin inhibition of Agrp that became sta-
tistically signiﬁcant in both Agrp-KI and Pomc-KI mice
(Fig. 5B). These data provide critical support for the
mechanism proposed by Barsh and colleagues (37), ac-
cording to which AgRP neurons are regulated by insulin in
both a cell-autonomous manner (explaining Agrp inhibi-
tion in Agrp-KI mice) and a nonautonomous manner that
includes POMC neurons (explaining Agrp inhibition in
Pomc-KI mice) and other inhibitory postsynaptic neurons
(explaining the trend toward lower Agrp levels in L1
mice).
In summary (Fig. 6), hypothalamic insulin signaling
controls both glucose metabolism and energy balance.
InsR signaling in AgRP neurons restrains HGP indepen-
dent of energy expenditure, whereas one-sided InsR acti-
vation in POMC neurons results in increased HGP. In
addition, Pomc-KI mice show increased energy expen-
diture without attendant hypophagia. The rebound hy-
perphagia in Pomc-KI mice is probably due to
hypoleptinemia and lack of concurrent inhibition of
anabolic AgRP neurons.
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FIG. 3. Hypothalamic expression of KATP channel subunits. A and B: mRNA expression of Abcc8 and Kcnj11 quantiﬁed by real-time RT-PCR in
whole hypothalamic lysates of 14- to 16-week-old wild-type, L1, Agrp-KI, and Pomc-KI male mice after overnight fasting or at the end of
hyperinsulinemic-euglycemic clamps (n  7–12). C: mRNA expression of Abcc8 in whole hypothalamic lysates of 15-week-old Foxo1
ﬂox/ﬂox
(control) and Foxo1
ﬂox/ﬂox::Pomc-Cre (Foxo1
POMC) male mice after 16-h fasting/6-h refeeding (n  6). All values are means  SEM. *P < 0.05
versus wild type, #P < 0.05.
TABLE 1
Synaptic contacts in L1 and Pomc-KI mice
Genotype n
Asymmetric
(stimulatory)
contacts
Symmetric
(inhibitory)
contacts
Total
synapses
WT 4 8  2 15.33  3.06 23.22  3.98
L1 5 8.5  1.5 6  1.68* 14.5  2.11*
Pomc-KI 5 12  2.36 4  1.33* 15  3.03*
Data are connections/100 	 of perikaryal membrane. *P  0.05 by
Mann-Whitney U test.
H.V. LIN AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, FEBRUARY 2010 341DISCUSSION
Our ﬁndings support a branched-pathway model of hypo-
thalamic insulin action (Fig. 6). In essence, 1) hypotha-
lamic regulation of HGP by insulin appears to be a
cell-autonomous response mediated by AgRP neurons;
and 2) regulation of locomotor activity and energy expen-
diture appears to occur in a cell-autonomous manner via
POMC neurons. Based on the ﬁndings of Balthasar et al.
(12), it can be inferred that this response is mediated by
second-order MCR neurons distinct from those in the
paraventricular hypothalamus (PVH). Finally, 3) the an-
orexigenic response to insulin appears to require direct
coregulation of POMC and AgRP neurons, as suggested by
Barsh and colleagues (37). The physiologic implication of the
present work is that different subsets of neurons mediate the
pleiotropic actions of insulin in the hypothalamus.
Mechanisms of increased HGP in Pomc-KI mice. The
increase of HGP in Pomc-KI mice has three likely compo-
nents: 1) a modest increase in hepatic glucose-6-phospha-
tase expression; 2) hypermetabolic state, acting perhaps
to increase substrate ﬂux to the liver (38); and 3) de-
creased hypothalamic KATP channels. Insulin hyperpolar-
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activation of KATP channels in the mediobasal hypothala-
mus that results in HGP inhibition (8,9). The complex
genetic makeup of Agrp-KI and Pomc-KI mice precludes
direct electrophysiological studies. But Abcc8 expression
was signiﬁcantly lower in Pomc-KI mice than in any other
genotype during hyperinsulinemic clamps. It should be
noted that Abcc8 mRNA levels mirror SUR1 protein levels
(39). Thus, decreased Abcc8 correlates with insulin’s fail-
ure to inhibit HGP, and suggests that hypothalamic neu-
rons are constitutively depolarized in these mice, and
therefore resistant to insulin inhibition of their electrical
activity. Further evidence that the decrease of Abcc8 is
linked to InsR knock-in is provided by the observation that
FoxO1 ablation in POMC neurons phenocopies this effect.
Although the current data do not allow us to pinpoint the
site of Abcc8 reduction, the magnitude of the reduction
suggests that, in addition to POMC neurons, Abcc8 is also
reduced in other arcuate cells, potentially including AgRP
neurons, thereby increasing HGP. Together with the ob-
servation of decreased inhibitory synaptic contacts on
POMC neurons in L1 mice, these data indicate that lack of
InsR constitutively depolarizes hypothalamic neurons and
that one-sided restoration of InsR signaling in Pomc-KI
mice further decreases inhibitory synapses, presumably
because it inhibits POMC neuron electrical activity, thus
decreasing the need to recruit further inhibitory connec-
tions. The decrease of inhibitory contacts, in the presence
of normal excitatory contacts, sets the stage for increased
HGP. We also considered a potential contribution of
neuropeptide alterations to increasing HGP, as intracere-
broventricular infusion of -melanocyte-stimulating hor-
mone (MSH), a processing product of POMC, was shown
to acutely increase HGP (40). However, Pomc expression
in Pomc-KI mice was unaltered during the hyperinsuline-
mic clamp, arguing against a signiﬁcant change in MSH.
Future studies will be required to determine whether
hyperinsulinemia affects MSH release in Pomc-KI mice,
thus contributing to increased HGP.
Our ﬁndings signiﬁcantly expand upon a recent condi-
tional knockout study demonstrating that InsR in AgRP
neurons is necessary to suppress HGP (11). Our data go
further, and indicate that InsR in AgRP neurons is sufﬁ-
cient to confer insulin inhibition on HGP. However,
whereas IL-6 expression was decreased in liver of AgRP-
speciﬁc InsR knockouts during hyperinsulinemic clamps,
Agrp-KI mice showed no improvement in hepatic IL-6/
Stat3 signaling compared with L1, possibly reﬂecting differ-
ent duration of the fast prior to clamping (3–5 in this study vs.
16 h in the study by Ko ¨nner et al. [11]). In contrast to our
ﬁndings, conditional ablation of InsR in POMC neurons did
not result in abnormalities of HGP (11). The likeliest expla-
nation for this difference is that, under normal conditions and
in the presence of concurrent activation of InsR in AgRP
neurons, it would have been difﬁcult to detect an increase in
hepatic insulin sensitivity in Pomc-InsR knockouts. The data
underscore the need to examine these complex questions
using different models.
Diverging effects of InsR signaling on locomotor
activity and feeding behavior. The reciprocal changes
in locomotor activity observed in L1, Agrp-KI, and
Pomc-KI provide evidence for a dominant role of hypotha-
lamic InsR signaling in regulating this process. The hypo-
thalamic effects of insulin on energy homeostasis are
mediated primarily through the MCR system (32). Our data
suggest that the locomotor/energy expenditure branch of
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POMC neurons, whereas the food intake branch of MCR
signaling is largely unaffected by it. This is consistent with
the demonstration that these two branches of MCR signal-
ing are regulated by different neuronal subpopulations,
with the PVH subset being more important for food intake
(12). Accordingly, it can be inferred that InsR signaling is
coupled primarily to POMC neurons that project to sec-
ond-order MCR neurons distinct from those residing in the
PVH. In addition to the PVH, ARC POMC neurons also
project widely throughout the brain, including to the
lateral hypothalamus, amygdala, and reticular nucleus
(41). Lateral hypothalamus hypocretin and melanin-con-
centrating hormone neurons have been implicated in the
regulation of energy expenditure, but we failed to detect
differences in mRNA levels, indicating that the contribu-
Hypothalamic
InsR OFF
Agrp
InsR ON
Locomotor Activity
HGP
Pomc
InsR ON
Energy expenditure
Locomotor Activity
KATP
HGP
Hypothalamic 
InsR OFF
FIG. 6. Branched pathways in hypothalamic InsR action. InsR activation in AgRP neurons restrains HGP independent of locomotor activity/energy
expenditure. In contrast, InsR activation in POMC neurons results in increased HGP (in part through downregulation of KATP channels and
activation of a hypermetabolic state) and increased locomotor activity/energy expenditure.
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any—does not involve changes in gene expression. A
recent study suggested that Stat3 signaling in AgRP neu-
rons controls locomotor activity via secondary dopaminer-
gic neurons in the striatum and frontal cortex (42). Further
studies will be required to ascertain the contribution of
POMC neurons in the nucleus of the solitary tract (41) and
the role of secondary dopaminergic neurons to the ob-
served phenotype.
The dissociation of InsR pathways regulating energy
expenditure from those regulating food intake provides a
likely explanation for the absence of obesity in the three
models of hypothalamic insulin resistance presented in
this article, unlike NIRKO mice (4). Although Pomc-KI
mice show a trend toward increased rebound feeding, it
should be considered that they are relatively hypoleptine-
mic. It bears emphasizing that Pten ablation in POMC
neurons leads to hyperphagia and hyperleptinemia (21),
consistent with the concept that the balance of hypotha-
lamic InsR signaling is a key determinant of leptin produc-
tion. The mechanism linking InsR hypothalamic signaling
to leptin expression in adipocytes may involve nutritional
and hormonal inputs and sympathetic nervous system
cues (43). Hyperinsulinemia can induce sympathoactiva-
tion via PI 3-kinase and mitogen-activated protein kinase
signaling in the rat mediobasal hypothalamus (44). It will
be of interest to determine whether insulin action in
POMC neurons regulates the sympathetic nervous system
and contributes to the tonic inhibition of leptin produc-
tion.
In conclusion, we demonstrate that different subsets of
hypothalamic neurons mediate different branches of insu-
lin’s metabolic and energy expenditure actions. The data
delineate an anatomic-functional map of hypothalamic
insulin signaling that will be useful to interpret safety and
efﬁcacy data of antiobesity medications with a central
mechanism of action.
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